SCHEMBL22948261

SCHEMBL22948261

C[Si]1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4ccccc34)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORA P35398 1/20 0.37
RORC P51449 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 7/20 0.35
KMT2A Q03164 7/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
HPGD P15428 4/20 0.35
ATM Q13315 2/20 0.34
TSHR P16473 3/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
NTSR1 P30989 1/20 0.32
PDE5A O76074 2/20 0.32
KDM4E B2RXH2 3/20 0.31
LMNA P02545 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947413 0.99 RORA (0.36) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22948260 0.99 RORA (0.36) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22947318 0.95 RORA (0.34) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22947414 0.94 RORA (0.34) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22947421 0.93 RORA (0.34) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22948220 0.92 L3MBTL1 (0.36) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22947297 0.91 MEN1 (0.37) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22948065 0.91 L3MBTL1 (0.35) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22948217 0.91 L3MBTL1 (0.35) RORARORCL3MBTL1MEN1KMT2A
SCHEMBL22947258 0.89 L3MBTL1 (0.33) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 RORA 319/4885RORC 247/4885L3MBTL1 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.